| Tag | Content |
|---|
EnhancerAtlas ID | HS093-07830 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr12:118744670-118746690 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr12:118744774-118744785 | ATTTTAATTAA | + | 6.62 | | Nkx3-2 | MA0122.3 | chr12:118744762-118744775 | TTTAAGTGTTTAA | - | 6.37 | | SPI1 | MA0080.4 | chr12:118746059-118746073 | AAAAAGGGGAAGCA | + | 6.11 | | SPIC | MA0687.1 | chr12:118746059-118746073 | AAAAAGGGGAAGCA | + | 6.19 | | SRF | MA0083.3 | chr12:118746043-118746059 | TTACCCTATATGGTCT | + | 6.07 | | Sox3 | MA0514.1 | chr12:118745282-118745292 | CCTTTGTTTT | + | 6.02 | | ZNF263 | MA0528.1 | chr12:118745011-118745032 | CTTCCCGCCTCCTCTTCCCCC | - | 6.3 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_13388 | chr12:118744123-118746042 | CD34_Primary_RO01536 | | SE_59664 | chr12:118737555-118816425 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr12 | 118746212 | 118746345 | | chr12 | 118744725 | 118745093 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I118306 | chr12 | 118744147 | 118747210 |
|
Enhancer Sequence | ACTTCATTTG CACTATCCAA TAATGGTAGC CATTAACAAC ATGTGGCTAG TAAGCACTTG 60
AAATGTGGCT AGTGCAACAG AAGAACGGAA TTTTTAAGTG TTTAATTTTA ATTAATTTTC 120
ATTTAAATAG CTCTTTGGCT AGAAACTACA ATGTTGGACA ACACAGTTCT AGATAGTTCA 180
AAAAACATCA GTAATTATGT GGAAATAGAA TAATAATGAT TCTCATTACT AAACTATACA 240
GGTTATATCA TTGCCTCAGG AATTGCTGAC ACATCTCTTG ACCAATTGTG CAAGAAGCAA 300
TGAGGTTTTG AGCACGGTTT TTTACCACTT TATGAATCAA CCTTCCCGCC TCCTCTTCCC 360
CCCCCCATCT CTGGAGTCCT CATAGTTTTC TCTTTAAAAT CATTTGTAAA ACAGAAAGCA 420
AAGCTCTCAG ATCTAACCAG TAGTCTAACT CTGACCTTAG GCTCCCACGG GAATTCAATT 480
ATTTTTGTTG GCCTAACCTC TAAGGGATGA TGGATTTGCT ATCTCTGTGT CCTCCTTCTT 540
CCCTGACTCC CCCTCCCACC CTCACATCTT CTCCTCTAAC TAGTCACATT TAGTTAGTTT 600
CTTGACCTGC TGCCTTTGTT TTAAACAGGA ATGAAAGAGA ACCATAACTG GAAACAGAAA 660
CTGTTGCATT CAGTTATTAG GTCGCAATGG GAAAAATGAG GCTGTGTATG TATAAGTGTT 720
TTTGCAGGGT TTAGGATAGC AGCTGCAGCT ACCCCTTCTT TCCTTCCACT GCTAGACAAA 780
TTTCCAAGCA CTTGATACTA GAGTTCTACC ACTAGCTAGC CAGCTAGAGG TCTCGGTATC 840
CTCTATGAAC TGTTAATGAA GTTCCGGAAG TTCTTTCCTT AAAAAACAAA AGTTCTGAAT 900
GCTGACTCTC TAACCACGGA AATGGTATCT TATTACTAAA ACACTAAAAA TGTTAAGCTG 960
CATACTGCTC CAATGAGTAG TCTGTAGACT TGTTACCATC TGTACTGGCC ATAGCGAAAA 1020
AGGGTTTGAC ACTACATGAT AGTTACTGGT ACTTGTTCCC AATAGCTGCT TAAAATAAGC 1080
TGTTGGCAAG TTTGACTACT TTTTTTTTTT TTTTACATTT AAAAAATAAC AACATTAAAC 1140
AGTTATATCT GTAAATGTAA GAAGGTTAAG GCATTCTAAG TCACAGGATG GGATAGGAGG 1200
TAGGCACAAG ATACAGGTCA TAAAGACCTT GCTGATAAAA CAGGTTGCAG TAAAGAAGCC 1260
GGCCAAAACC CACCAAAACC AAGATGGCAA TGAGAATGAC CTCTGGTCGT CCTCACTGCT 1320
ATACTCCCAC CAATGCCATG ACAGTTTACA GATGCCACGG CAACATCAGG AAGTTACCCT 1380
ATATGGTCTA AAAAGGGGAA GCATGAATAA TAGACCCTTT GTTTAGCATA TCATCAAGAA 1440
ATAACCATAA AACTGGGCAA CCAGCAACCC CCCGGGGCTG CTCTGTCTGT GGAGTAGCCA 1500
TTCTTTTATG CCTTTACTTT CTTAATAAAC TTGCTTTCAC TTAAAAAAAA AATTAAACAT 1560
TTACATTTGT ATAAAGTACT TTCACATACC TAACCAAATT CAATTATTTT AACAACCCAG 1620
TAAGGCAGGA AAATCAGTTA TTATTATTCT GATTTTTATG AGTGTCATCT GACTCCTAGG 1680
ATAGCAGCAT GTTTCCCAGT ATACCAGTAC TTCTACCTGG CAAGGGTGCT GCCCAAAAAT 1740
GGTCTTGGGA GAATGTAGAC GGTGTAGAAA AGTCTGTAAT TTGGCCGGGC GCGGTGGCTC 1800
ACACCTGTAA TGGCAGCATT TTGGGAGGCC GAGGCAGGTG GATTACCTGA GGTCAGGAGT 1860
TTGAGACCAG CCTGACTAAC ATGGTAAAAC CCTGTCTCTA CTAAAAATAC AAAAATTAGC 1920
CAGGCGTGGT GGCACATGCC TGTAATCCCA GCTACTTGGG AGGCTGAGGC AGGAGACTCG 1980
TTTGAACCCA GGAGGCGGAG GTTGCAGTGA CCTGAGATCG 2020
|
